JTO Clinical and Research Reports (Jun 2021)

Interest in Cessation Treatment Among People Who Smoke in a Community-Based Multidisciplinary Thoracic Oncology Program

  • Meghan Meadows-Taylor, PhD,
  • Kenneth D. Ward, PhD,
  • Weiyu Chen, MPH,
  • Nicholas R. Faris, M.Div,
  • Carrie Fehnel, BBA,
  • Meredith A. Ray, PhD,
  • Folabi Ariganjoye, M.B.B.S.,
  • Courtney Berryman, AA,
  • Cheryl Houston-Harris, BS,
  • Laura M. McHugh, RN,
  • Alicia Pacheco, MHA,
  • Raymond U. Osarogiagbon, M.B.B.S.

Journal volume & issue
Vol. 2, no. 6
p. 100182

Abstract

Read online

Introduction: To evaluate the need for tobacco cessation services within a multidisciplinary clinic (MDC), we surveyed patients on their smoking status, interest in quitting, and willingness to participate in a clinic-based cessation program. We further evaluated the association between interest in cessation or willingness to participate in a cessation program and overall survival (OS). Methods: From 2014 to 2019, all new patients with lung cancer in the MDC at Baptist Cancer Center (Memphis, TN) were administered a social history questionnaire to evaluate their demographic characteristics, smoking status, tobacco dependence, interest in quitting, and willingness to participate in a cessation program. We used chi-square tests and logistic regression to compare characteristics of those who would participate to those who would not or were unsure and Kaplan-Meier curves and Cox regression to evaluate the association between cessation interest or willingness to quit and OS. Results: Of 641 total respondents, the average age was 69 years (range: 32–95), 47% were men, 64% white, 34% black, and 17% college graduates. A total of 90% had ever smoked: 34% currently and 25% quit within the past year. Among the current smokers, 60% were very interested in quitting and 37% would participate in a cessation program. Willingness to participate in a cessation program was associated with greater interest in quitting (p < 0.0001), better OS (p = 0.02), and reduced hazard of death (hazard ratio = 0.52, 95% confidence interval: 0.30–0.88), but no other characteristics. Conclusions: Patients with lung cancer in an MDC expressed considerable interest in tobacco cessation services; patients willing to participate in a clinic-based cessation program had improved survival.

Keywords